Fig. 1From: Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systemsPRISMA flow diagram. AAO, American Academy of Ophthalmology; ARVO, Association for Research in Vision and Ophthalmology; APAO, Asia-Pacific Academy of Ophthalmology; EURETINA, European Society of Retina Specialists; ISPOR, International Society for Pharmacoeconomics and Outcomes Research; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; SLR, systematic literature review. The dotted line represents a manual search of the APAO abstract bookBack to article page